SCHEMBL13009151

SCHEMBL13009151

Cc1c2ccc(N3c4ccccc4Sc4ccccc43)cc2c(C)c2ccc(N3c4ccccc4Sc4ccccc43)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.44
MAOA P21397 1/20 0.44
NOX1 Q9Y5S8 2/20 0.39
MEN1 O00255 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
CHRM3 P20309 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
DRD3 P35462 1/20 0.38
HTR2B P41595 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
BCHE P06276 12/20 0.37
ALDH1A1 P00352 1/20 0.36
PTGS1 P23219 2/20 0.36
PTGS2 P35354 2/20 0.36
ACHE P22303 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17915737 0.84 HDAC6 (0.47) HDAC6MAOANOX1MEN1ADRA2A
SCHEMBL17915741 0.84 HDAC6 (0.47) HDAC6MAOANOX1MEN1ADRA2A
SCHEMBL17109672 0.82 MAOA (0.47) HDAC6MAOANOX1MEN1ADRA2A
SCHEMBL13427127 0.81 HDAC6 (0.41) HDAC6MAOANOX1MEN1ADRA2A
SCHEMBL13615783 0.80 HDAC6 (0.44) HDAC6MAOANOX1MEN1ADRA2A
SCHEMBL13615968 0.80 HDAC6 (0.44) HDAC6MAOANOX1MEN1ADRA2A
SCHEMBL27339984 0.80 HDAC6 (0.44) HDAC6MAOANOX1MEN1ADRA2A
SCHEMBL13427113 0.80 HDAC6 (0.41) HDAC6MAOANOX1MEN1ADRA2A
SCHEMBL13009150 0.80 HDAC6 (0.44) HDAC6MAOANOX1MEN1ADRA2A
SCHEMBL14073460 0.80 MAOA (0.44) HDAC6MAOANOX1MEN1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-2141214-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A HDAC6 4054/4885MAOA 1343/4885NOX1 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.